AMD ceases to be a cause of blindness with the right treatment

This was the headline of a recent article published by the El Periódico newspaper on the evolution of the treatment of Age-Related Macular Degeneration (AMD). In the words of Dr. Jordi Monés, AMD “has gone from being a disease which causes irreversible blindness to a chronic disease which reawakens the hope of those who suffer it”.

The article appeared in the Da+Visión programme, which is promoted by Novartis with the collaboration of the Institut de la Màcula and the Spanish Society of Low Vision Specialists (SEEBV).

A total of 707,857 people currently live with AMD in Spain. Globally, the figure rises to 150 million. If the disease is treated, up to 30% of patients may be able to recover some of their lost vision and three out of every four patients to have followed the treatment correctly halt the deterioration in their sight.  

Read the article (Spanish): 131105_El Periodico_JMones